Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Monitoring of minimal residual disease in acute myeloid leukemia: methods and best applicationsJeffrey L Jorgensen, Su S Chen
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|September 4, 2009
t(10; 12) (q24; p13) as the sole abnormality in a case with refractory acute myeloid leukemia: The first case report and literature reviewGary Lu, Inga Gurevich, Binh T Vo, et al.
American Journal of Clinical Pathology|February 26, 2011
Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remissionJianlan Sun, C Cameron Yin, Wei Cui, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 30, 2010
De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classificationJianlan Sun, Sergej N Konoplev, Xuemei Wang, et al.
American Journal of Clinical Pathology|January 21, 2012
CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemiaDaniela Hoehn, L Jeffrey Medeiros, Su S Chen, et al.
Cancer Genetics and Cytogenetics|February 2, 2010
Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutationsLaura Millecker, Patrick A Lennon, Srdan Verstovsek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 26, 2009
Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood stagingBo Feng, Jeffrey L Jorgensen, Dan Jones, et al.
American Journal of Clinical Pathology|April 17, 2009
Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcomeSteven A Gustafson, Pei Lin, Su S Chen, et al.
Annals of Surgery|September 11, 2013
RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastasesJean-Nicolas Vauthey, Giuseppe Zimmitti, Scott E Kopetz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2009
Application of COLD-PCR for improved detection of KRAS mutations in clinical samplesZhuang Zuo, Su S Chen, Pranil K Chandra, et al.
Pageof 2